Minimizing treatment variability requires a multifaceted approach. Strategies include conducting well-designed clinical trials that account for diverse populations, improving healthcare access and quality, and implementing guidelines that standardize treatment protocols. Enhancing patient education and adherence to prescribed regimens can also reduce variability. Furthermore, advances in pharmacogenomics and precision medicine hold promise for tailoring treatments to individual genetic profiles, thereby minimizing variability.
